Modulators of p-selectin glycoprotein ligand 1

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/395 (2006.01) C07K 16/28 (2006.01)

Patent

CA 2428822

Compounds that bind to P-Selectin Glycoprotein 1 (PSGL-1) on the surface of T cells or natural killer (NK) cells can be used to induce T cell or NK cell depletion and/or to induce T cell or NK cell apoptosis. The compounds and methods of the invention can be used to control unwanted T cell- or NK cell- mediated immune responses in conditions such as autoimmune diseases, transplant rejection, and allergic diseases.

L'invention concerne des composés qui se lient à la Glycoprotéine 1 P-Sélectine (PSGL-1) sur la surface des lymphocytes T ou des cellules NK. Les composés selon l'invention peuvent être utilisés pour induire la déplétion des lymphocytes T ou des cellules NK et/ou induire l'apoptose des lymphocytes T ou des cellules NK. Les composés et les procédés selon l'invention peuvent être utilisés pour réguler les réponses immunitaires à médiation de lymphocytes T ou de cellules NK non désirées dans des affections telles que les maladies auto-immunes, les rejets de greffe et les maladies allergiques.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Modulators of p-selectin glycoprotein ligand 1 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Modulators of p-selectin glycoprotein ligand 1, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modulators of p-selectin glycoprotein ligand 1 will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1671232

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.